• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Workflow Guide

  2026-04-30

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive, specific detection of rabbit primary antibodies in immunoassays such as Western blot, ELISA, IHC, and IC. It is best used where high specificity and robust signal amplification are required, but should not be used for diagnostic or therapeutic purposes, or in cross-species applications without verifying cross-reactivity profiles.

• CLK2 Inhibition as a Strategy to Overcome Platinum Resistanc

  2026-04-30

  This article reviews recent evidence that upregulation of Cdc2-like kinase 2 (CLK2) promotes platinum resistance in ovarian cancer by enhancing DNA damage repair through BRCA1 phosphorylation. Targeting CLK2 represents a promising avenue for alternative splicing modulation and improved therapeutic response in resistant ovarian cancer models.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-04-29

  Wang et al. (2018) systematically dissected the entry mechanism of genotype III grass carp reovirus (GCRV104), revealing a strict dependence on clathrin-mediated, pH-dependent endocytosis. Their pharmacological inhibitor analysis clarifies the limited role of Pak1 signaling in this model, guiding future antiviral strategy development.

• Casticin Inhibits NSCLC Cell Proliferation via Glycolytic Re

  2026-04-29

  This study demonstrates that casticin, a flavonoid compound, suppresses non-small cell lung cancer (NSCLC) cell proliferation by inhibiting glycolytic metabolism through HIF-1α modulation. The findings clarify the metabolic mechanism underlying casticin’s anticancer effect and suggest a novel metabolic vulnerability in NSCLC, with implications for targeted therapy design.

• Miltefosine’s Dual Signaling Impact: Precision Tools for Hem

  2026-04-28

  Explore how Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) uniquely integrates PI3K/Akt inhibition and Ras/MEK/ERK activation, enabling advanced experimental design in cancer and hematology research. This article unpacks new mechanistic insights and practical guidance beyond standard protocols.

• AZD3463: Redefining ALK/IGF1R Inhibition for Translational O

  2026-04-28

  This thought-leadership article dissects the mechanistic and strategic dimensions of AZD3463, an advanced oral ALK/IGF1R inhibitor. We bridge rigorous preclinical data with actionable guidance for translational researchers, contextualize AZD3463’s impact on neuroblastoma and ALK-driven cancer research, and highlight how this analysis deepens the conversation beyond typical product summaries.

• Nicotinamide Adenine Dinucleotide (NAD+): Applied Workflows

  2026-04-27

  Nicotinamide Adenine Dinucleotide (NAD+) enables precise interrogation of metabolic signaling, autophagy, and DNA damage pathways. This guide delivers actionable protocols and troubleshooting tailored for stress adaptation research, drawing on new evidence linking NAD+ to cytoprotective autophagy and caspase-driven DNA repair. Researchers gain both experimental clarity and strategic tips for robust, reproducible results.

• (+)-Bicuculline: Practical Guide for GABAA Receptor Antagoni

  2026-04-27

  (+)-Bicuculline is a well-established GABAA receptor antagonist used to dissect inhibitory neurotransmission and synaptic NMDA receptor signaling modulation in neuroscience research. It is intended exclusively for controlled laboratory use and is not suitable for diagnostic or clinical applications. Proper handling of its solubility and storage requirements is crucial for reproducible results.

• ChaC1-Based Drug Screening Reveals Synergy in HCC Therapy

  2026-04-26

  This study pioneers ChaC1-guided drug screening to uncover a potent synergistic cytotoxic effect between auranofin and proteasome inhibitors in hepatocellular carcinoma (HCC) cells. By leveraging FDA-approved drug libraries, the authors highlight glutathione metabolism as a vulnerability in HCC, suggesting repurposing strategies for existing drugs.

• Coronavirus Macrodomain Counters PARP-Mediated Antiviral Def

  2026-04-25

  This study reveals that the coronavirus macrodomain is essential for evading host poly(ADP-ribose) polymerase (PARP)-mediated inhibition of viral replication and for suppressing interferon responses. The findings highlight the mechanistic interplay between viral macrodomains and host PARP enzymes, with implications for antiviral research and immunomodulation.

• Perphenazine in Host-Directed Antibacterial Immunology Resea

  2026-04-24

  Explore the advanced use of Perphenazine as a dopamine D2 receptor antagonist in host-directed antibacterial immunology research. This article reveals novel mechanisms of action and design strategies beyond standard neuropharmacology applications.

• Auranofin: Precision Thioredoxin Reductase Inhibitor for Can

  2026-04-24

  Auranofin is a potent thioredoxin reductase inhibitor that disrupts cellular redox balance, induces apoptosis, and acts as a radiosensitizer in tumor models. Its nanomolar inhibition potency and distinct solubility profile make it a versatile tool for redox biology and cancer research. APExBIO’s Auranofin B7687 enables protocol-driven studies targeting redox and apoptotic pathways.

• ERK Signaling in IFNγ-Induced Melanoma Cell Death: Mechanism

  2026-04-23

  Champhekar et al. (2023) elucidate the mechanism by which interferon-gamma (IFNγ) induces apoptosis in melanoma through ERK pathway activation, identifying critical molecular mediators and demonstrating pathway dependency across diverse tumor genotypes. These findings refine our understanding of IFNγ's antitumor effects and inform targeted pathway modulation strategies in cancer research.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Benchmarking Dual Reporter

  2026-04-23

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) elevates Cy5-labeled mRNA delivery and immune-modulation assays. This article uniquely analyzes its integration with advanced nanoparticle platforms and real-time functional readouts for translational research.

• Machine Learning Uncovers New Senolytics for Cancer Research

  2026-04-22

  This article examines a recent study leveraging machine learning to identify novel senolytic compounds by screening published data, significantly reducing drug discovery costs. The findings have important implications for targeting senescent cells in cancer and aging research, and are compared with established approaches and resources for EGFR and ErbB2 inhibition.

15561 records 1/1038 page Next 12345 下5页 Last page